Type 2 Diabetes (T2D) Clinical Trials

Find Type 2 Diabetes (T2D) Clinical Trials Near You

Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In this study, investigators wanted to determine the effect of T2DM susceptibility gene mutations on self-expression. Participants (T2DM patients and controls) were recruited to identify genotypes and detect the levels of T2DM susceptibility genes expression in the fresh peripheral plasma. The normal pancreatic tissues or adjacent tissues of pancreatic cancer were also collected to identify the expression differences of T2DM susceptibility genes under different genotypes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 25
Maximum Age: 70
Healthy Volunteers: t
View:

• no drug therapy; 25 to 70 years old; Hemoglobin A1c (HbA1c) 7%-12%; BMI 20-35 kg/m2; Stable body weight (≤10% change within 3 months)(For newly diagnosed patients with T2DM).

• 25 to 60 years old; BMI 19-26 kg/m2; in good health, with no abnormalities of motor system, digestive system, respiratory system, urogenital system, blood system, circulatory system, nervous/mental system, endocrine system, etc(For healthy subjects).

• 20-80 years old; surgical resection of part or all of the pancreas; pancreatic lesions confirmed by enhanced CT or magnetic resonance (MR) examination or confirmed by intraoperative and postoperative pathology(For the patients in general surgical).

Locations
Other Locations
China
China, Jiangsu, Department of Endocrinology
RECRUITING
Xuzhou
Contact Information
Primary
Tao Wang, Ph.D
misswt2011@126.com
13815344640
Backup
Xiaoxing Yin, Ph.D
yinxx@xzmc.edu.cn
13605218523
Time Frame
Start Date: 2024-01-01
Estimated Completion Date: 2028-01-31
Participants
Target number of participants: 300
Treatments
Experimental: Comparison of T2DM susceptibility gene expression between newly diagnosed T2DM patients and controls
To determine the effect of gene mutations on the susceptibility of T2DM by comparing the expression levels of T2DM susceptibility genes in newly diagnosed T2DM patients and controls.
Sponsors
Leads: The Affiliated Hospital of Xuzhou Medical University

This content was sourced from clinicaltrials.gov